Moderna Inc

Common Name
Moderna
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
5,800
Ticker
MRNA
Exchange
NASDAQ/NGS
Description
Moderna Inc. is a biotechnology company focused on developing transformative medicines based on messenger RNA (mRNA) technology. Its primary function is to research and produce a broad spectrum of vac...

Moderna's GHG Emissions Data Preview

In 2023, Moderna completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Moderna has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Moderna’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Moderna’s data sources below and access millions more through our Disclosure Search.

a. Moderna's ESG Report 2023
a. Moderna's ESG Report 2023

Insights into Moderna's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Moderna amounted to 22,746 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Moderna increased by 2.03%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Moderna's Scope 1 Emissions Over Time

20212022202303 k6 k9 k12 ktCO2e+26%-3%
  • Total Scope 1
  • Year-over-Year Change

What are Moderna's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Moderna were 11,240 metric tons of CO₂ equivalent (tCO₂e). a

Has Moderna reduced its Scope 1 emissions over time?

Since 2021, Moderna's Scope 1 emissions have increased by 22.95%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), Moderna's Scope 1 emissions decreased by 2.79%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Moderna's Scope 2 emissions?

In 2023, Moderna reported Scope 2 greenhouse gas (GHG) emissions of 431 tCO₂e using the market-based method and 11,506 tCO₂e using the location-based method. a

Has Moderna reduced its Scope 2 emissions over time?

Since 2021, Moderna's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 41.72%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2022), Moderna's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Moderna 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Moderna use for Scope 2 reporting?

In 2023, Moderna reported its Scope 2 emissions using the market-based method and using the location-based method. a

Moderna's Scope 2 Emissions Over Time

20212022202303 k6 k9 k12 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Moderna’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Moderna reported Scope 1 greenhouse gas (GHG) emissions of 11,240 tCO₂e and total revenues of USD 6,754 millions. This translates into an emissions intensity of 1.66 tCO₂e per millions USD. a

Moderna's Scope 1 Emissions Intensity Compared to Peers

1005005,00050,000500,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)RIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MIlluminaYear: 2024Scope 1: 18,836 tCO2eRevenue: $M 4,372Scope 1 Intensity: 4.31 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MElanco Animal HealthYear: 2024Scope 1: 175,807 tCO2eRevenue: $M 4,439Scope 1 Intensity: 39.61 tCO2e/$MOrganon & CoYear: 2024Scope 1: 34,200 tCO2eRevenue: $M 6,403Scope 1 Intensity: 5.34 tCO2e/$MRRRevvityYear: 2023Scope 1: 2,121 tCO2eRevenue: $M 2,751Scope 1 Intensity: 0.77 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MDexcomYear: 2023Scope 1: 5,383 tCO2eRevenue: $M 3,622Scope 1 Intensity: 1.49 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MModernaYear: 2023Scope 1: 11,240 tCO2eRevenue: $M 6,754Scope 1 Intensity: 1.66 tCO2e/$M

How does Moderna's GHG emissions intensity compare to its peers?

In 2023, Moderna reported a Scope 1 emissions intensity of 1.66 tCO₂e per millions USD. Compared to the peer group median of 2.76 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Moderna rank on GHG emissions intensity within its industry?

In 2023, Moderna ranked 7 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Moderna is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Moderna's GHG Emissions Dataset?
Sign Up